Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma

Table 2 Soluble levels of VCAM-1, CEA in gastric cancer patients, ulcer patients and control group

	n	Soluble VCAM-1(μg/ml) (¯x ± s)	CEA
Gastric cancer	41	878 ± 46a	4.7 ± 0.43
I-II	17	764 ± 24b	4.1 ± 0.23
III-IV	24	1006 ± 78c	4.9 ± 0.31
Ulcer	8	301 ± 21	4.5 ± 0.41
Control	25	297 ± 35	2.3 ± 0.28

^aP < 0.05,

^bP < 0.05,

^cP < 0.05, (vs control group).